Bristol-Myers Squibb Company News Headlines

BMY 
$51.51
*  
0.39
0.76%
Get BMY Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
9/19/2014 5:40:00 PM - Zacks.com

XLV, JNJ, AMGN, BMY: ETF Inflow Alert
9/19/2014 11:00:14 AM - BNK Invest

Why You Should Sell Bristol-Myers Squibb And Buy Johnson & Johnson Instead
9/19/2014 8:43:00 AM - Seeking Alpha

Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog
9/18/2014 4:55:00 PM - Zacks.com

Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
9/18/2014 10:57:44 AM - Motley Fool

Bristol-Myers Squibb To Present In BoA Merrill Lynch Conference At 4:45 AM ET
9/18/2014 3:45:00 AM - RTT News

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 6:00:00 PM - Zacks.com

Daily Dividend Report: DX, MA, BMY, USB, CLX, FE
9/17/2014 2:04:05 PM - BNK Invest

3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 10:52:17 AM - InvestorPlace Media

Buy The Dip In Gilead: Why A Decrease In Quarterly Sovaldi Revenue Is Expected
9/16/2014 12:31:00 PM - Seeking Alpha

If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits
9/16/2014 8:00:00 AM - Seeking Alpha

Teva Pharmaceutical Is Poised To Grow
9/13/2014 7:49:00 PM - Seeking Alpha

In A Quiet Week, Affimed Therapeutics IPO Could Garner Investor Interest
9/11/2014 3:17:00 PM - Seeking Alpha

Health Care Select Sector SPDR Fund Experiences Big Inflow
9/11/2014 11:42:08 AM - BNK Invest

Achillion - An Options Strategy For A Potential Acquisition
9/8/2014 6:07:00 PM - Seeking Alpha

Bristol-Myers Sues Merck of Patent Infringement on Keytruda - Analyst Blog
9/8/2014 4:30:00 PM - Zacks.com

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza
9/8/2014 1:57:39 PM - Trefis

Bristol-Myers Squibb To Present At Morgan Stanley Conference; Webcast At 2:00 PM
9/8/2014 1:00:00 PM - RTT News

Novartis Is Expanding Its Portfolio Effectively
9/8/2014 11:33:00 AM - Seeking Alpha

The Surprising 7 States Where Melanoma Most Often Occurs
9/7/2014 11:52:02 AM - Motley Fool

BMY Makes Bullish Cross Above Critical Moving Average
9/5/2014 3:54:51 PM - BNK Invest

Merck's Anti-PD-1 Drug Keytruda First to be Launched in US - Analyst Blog
9/5/2014 11:20:00 AM - Zacks.com

Bristol-Myers bulls looking for rally
9/5/2014 4:56:09 AM - optionMONSTER

Merck & Co., Inc. Wins First Stage of the PD-1 Race
9/4/2014 10:55:34 PM - Motley Fool

3 Reasons Bristol-Myers Squibb's Stock Could Fall
9/4/2014 4:42:24 PM - Motley Fool